Your browser doesn't support javascript.
loading
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.
Katz, R B; Toprak, M; Wilkinson, S T; Sanacora, G; Ostroff, R.
Affiliation
  • Katz RB; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA. Electronic address: Rachel.katz@yale.edu.
  • Toprak M; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Wilkinson ST; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Sanacora G; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Ostroff R; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
Gen Hosp Psychiatry ; 54: 62-64, 2018.
Article in En | MEDLINE | ID: mdl-30100209
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Ketamine / Monoamine Oxidase Inhibitors / Antidepressive Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Gen Hosp Psychiatry Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Ketamine / Monoamine Oxidase Inhibitors / Antidepressive Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Gen Hosp Psychiatry Year: 2018 Document type: Article